17 November 2017
News and Views
Links and Services
This month's issue of Gastroenterology investigates maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stopped.
It is important to determine whether infliximab therapy can be safely interrupted in patients wit
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors